0001213900-24-005754.txt : 20240123
0001213900-24-005754.hdr.sgml : 20240123
20240123161808
ACCESSION NUMBER: 0001213900-24-005754
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20240123
DATE AS OF CHANGE: 20240123
EFFECTIVENESS DATE: 20240123
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aditxt, Inc.
CENTRAL INDEX KEY: 0001726711
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 823204328
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-503204
FILM NUMBER: 24552872
BUSINESS ADDRESS:
STREET 1: 737 N. FIFTH STREET, SUITE 200
CITY: RICHMOND
STATE: VA
ZIP: 23219
BUSINESS PHONE: 909-488-0844
MAIL ADDRESS:
STREET 1: 737 N. FIFTH STREET, SUITE 200
CITY: RICHMOND
STATE: VA
ZIP: 23219
FORMER COMPANY:
FORMER CONFORMED NAME: Aditx Therapeutics, Inc.
DATE OF NAME CHANGE: 20201113
FORMER COMPANY:
FORMER CONFORMED NAME: ADiTx Therapeutics, Inc.
DATE OF NAME CHANGE: 20171229
D
1
primary_doc.xml
X0708
D
LIVE
0001726711
Aditxt, Inc.
737 N. FIFTH STREET
SUITE 200
RICHMOND
VA
VIRGINIA
23219
(650) 870-1200
DELAWARE
None
Aditx Therapeutics, Inc.
ADiTx Therapeutics, Inc.
Corporation
true
Amro
Albanna
737 N. Fifth Street
Suite 200
Richmond
VA
VIRGINIA
23219
Executive Officer
Director
Chief Executive Officer
Corinne
Pankovcin
737 N. Fifth Street
Suite 200
Richmond
VA
VIRGINIA
23219
Executive Officer
Chief Commercialization Officer
Rowena
Albanna
737 N. Fifth Street
Suite 200
Richmond
VA
VIRGINIA
23219
Executive Officer
Chief Operating Officer
Shahrokh
Shabahang
737 N. Fifth Street
Suite 200
Richmond
VA
VIRGINIA
23219
Executive Officer
Director
Chief Innovation Officer
Thomas
Farley
737 N. Fifth Street
Suite 200
Richmond
VA
VIRGINIA
23219
Executive Officer
Chief Financial Officer
Brian
Brady
737 N. Fifth Street
Suite 200
Richmond
VA
VIRGINIA
23219
Director
Jeffrey
Runge
737 N. Fifth Street
Suite 200
Richmond
VA
VIRGINIA
23219
Director
Charles
Athle
Nelson
737 N. Fifth Street
Suite 200
Richmond
VA
VIRGINIA
23219
Director
Biotechnology
Decline to Disclose
- 06b
false
2023-12-29
false
true
true
false
0
H.C. Wainwright & Co., LLC
375
None
None
430 PARK AVENUE
4TH FLOOR
NEW YORK
NY
NEW YORK
10022
CA
CALIFORNIA
false
6000000
6000000
0
false
1
495000
0
0
false
Aditxt, Inc.
/s/ Amro Albanna
Amro Albanna
Chief Executive Officer
2024-01-23